Iterum hopeful despite Phase III miss for sulopenemhttps://www.thepharmaletter.com/article/iterum-hopeful-despite-phase-iii-miss-for-sulopenem
Novel Antibiotic Sulopenem Misses Primary End Point in cIAI Trial - MPRhttps://www.empr.com/home/news/drugs-in-the-pipeline/novel-antibiotic-sulopenem-misses-primary-end-point-in-ciai-trial/
Stewardship / Resistance Scan for Dec 12, 2019 | CIDRAPhttp://www.cidrap.umn.edu/news-perspective/2019/12/stewardship-resistance-scan-dec-12-2019
Sulopenem Narrowly Misses Primary End Point in Phase 3 cIAI Studyhttps://www.contagionlive.com/news/sulopenem-narrowly-misses-primary-end-point-in-phase-3-ciai-study
The ID Pipeline: FDA Activity From the Week of December 8, 2019https://www.contagionlive.com/news/the-id-pipeline-fda-activity-from-the-week-of-december-8-2019

Showing topic

Sulopenem

Names and synonyms

  • Sulopenem
  • Sulopenem etzadroxil
  • NCT03357614